title: How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The itsy bitsy anemia problem.
authors.affiliation: Renal Division, Brigham and Women's Hospital and Harvard Medical School Boston, Boston, Massachusetts.
authors.forename: Ajay K
authors.initials: AK
authors.lastname: Singh
mesh_terms: D018798:Anemia, Iron-Deficiency / Q000517:prevention & control*; D001809:Blood Viscosity / Q000187:drug effects; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage* / Q000009:adverse effects; D006397:Hematinics / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D006435:Renal Dialysis; D051436:Renal Insufficiency, Chronic / Q000628:therapy*
chemical_list: D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa